Skip to main content

Table 1 Main demographic, clinical and treatment characteristics.

From: Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study

   Evaluable Patients (N = 135) No Evaluable Patients (N = 69)
Age (years) Mean (SD) 66.6(12.4) 65.6(11.1)
Gender Male 90 (66.7 %) 45(65.2 %)
Female 45 (33.3 %) 24(34.8 %)
Primary cancer site Lung 42 (31.1 %) 21(30.4 %)
Prostate 27 (20.0 %) 10(14.5 %)
Breast 19 (14.1 %) 5(7.3 %)
Others 47 (34.8 %) 33(47.8 %)
Worst paina Median (range) 8 (0–10) 8 (0–10)
RT dose 5 x 400 cGy 83 (61.5 %) 40(58.0 %)
1 x 800 cGy 42 (31.1 %) 20(29.0 %)
Other 10 (7.4 %) 9(13.0 %)
RT site Pelvis 57 (42.2 %) 21(32.8 %)
Spine 39 (28.9 %) 25(39.1 %)
Extremities 20 (14.8 %) 11(17.2 %)
Others 19 (14.1 %) 7(10.9 %)
Bisphosphonates YES 36 (26.7 %) 16(23.2 %)
NO 99 (73.3 %) 53(76.8 %)
Dexamethasone YES 41 (30.8 %) 17(26.6 %)
NO 92 (69.2 %) 47(73.4 %)
  1. Abbreviations: RT = radiotherapy
  2. aWorst pain recorded using the Brief Pain Inventory (BPI): ranged from 0–10